COVID-19 treatment during and after recovery: What to expect

  • Ari Fahrial Syam Medical Faculty, Universitas Indonesia-Cipto Mangunkusumo Hospital
DOI: https://doi.org/10.25220/WNJ.V04.S3.0011
Keywords: remdesivir, choloroquin, plasma convalescent, COVID-19, SARS-Cov2

Abstract

Currently, there are no clinically specific drug for COVID-19, neither novel treatments nor vaccines. Hospitals and researchers over the world are testing many different therapies on coronavirus-positive patients in an effort to find a potential COVID-19 treatment, a few medications that have been making a buzz in the science community such as remdesivir, hydroxychloroquine and chloroquine, favipiravir, oseltamifir, lopinavir/ritonavir, azithromycin, plasma convalescent, dexamethasone and stem cell.

Downloads

Download data is not yet available.

Author Biography

Ari Fahrial Syam, Medical Faculty, Universitas Indonesia-Cipto Mangunkusumo Hospital
Department of Internal Medicine

Submitted

2020-10-06
Accepted
2020-10-26
Published
2020-10-27
Issue
Vol. 4 No. S3 (2020)
Section
Articles

World Nutrition Journal provides immediate open access to its content under the Creative Commons Attribution License (CC BY 4.0). This permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.